Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,400.00    -250.00 (-5.38%)
Bid:
4,350.00
Ask:
4,450.00
Spread: 100.00 (2.299%)
Market Cap: £293.07m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Special dividend

21 Nov 2019 07:00

RNS Number : 1305U
Judges Scientific PLC
21 November 2019
 

21 November 2019

Judges Scientific plc

("Judges Scientific", "the Company", or "the Group")

Special dividend

 

The Board of Judges Scientific today announces that in order to prioritise the interests of its shareholders it has decided to pay a special dividend of £2.00 per ordinary share, totalling £12.4 million.

The Board has assessed the Group's cash resources, its robust cash generation and the Group's ability to borrow for acquisitions, which result from a sustained period of strong performance. The special dividend will absorb a modest proportion of the resources available to conduct acquisitions and the Board is therefore confident that this special dividend will not interfere with the execution of Judges' unchanged buy-and-build strategy.

Payment of the special dividend will be on Tuesday 10 December 2019 to shareholders on the register on Friday 29 November 2019. The shares will go ex-dividend on Thursday 28 November 2019. The special dividend will be funded from existing cash balances.

 

Alex Hambro, Chairman of Judges Scientific, commented: 

"The payment of this special dividend is a reflection of our constant focus on shareholders' interests. Following this payment, the Group will have returned to shareholders four and a half times the IPO price."

 

For further information please contact: 

 

Judges Scientific 

David Cicurel, CEO 

Brad Ormsby, Group FD 

Tel: +44 (0) 20 3829 6970 

 

Shore Capital (Nominated Adviser & Broker) 

Stephane Auton 

Edward Mansfield 

Tel: +44 (0) 20 7408 4090 

 

Liberum (Joint Broker)

Bidhi BhomaEuan Brown

Tel: +44 (0) 20 3100 2222

 

Media enquiries: 

Alma PR (Financial Public Relations) 

Rebecca Sanders-Hewett 

Sam Modlin 

 

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk 

 

Notes to editors: 

 

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 16 businesses acquired since it was re-admitted to AIM in 2005. 

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group companies hold five Queen's Awards for innovation and export.  

 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins. 

 

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.  

 

For further information, please visit www.judges.uk.com 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVKMMZMLGNGLZM
Date   Source Headline
27th Jun 20134:52 pmRNSHolding(s) in Company
27th Jun 20137:00 amRNSAcquisition and Trading Update
7th Jun 20133:24 pmRNSDirector/PDMR Shareholding
29th May 20135:17 pmRNSResult of AGM
10th May 20134:06 pmRNSDirector/PDMR Shareholding
12th Apr 20133:30 pmRNSIssue of Equity
9th Apr 201311:59 amRNSDirector/PDMR Shareholding
22nd Mar 20137:00 amRNSFinal Results
8th Mar 201311:30 amRNSNotice of Results
7th Mar 20132:41 pmRNSDirector/PDMR Shareholding
8th Feb 20133:54 pmRNSDirector/PDMR Shareholding
24th Jan 20137:00 amRNSTrading Statement
17th Jan 201310:55 amRNSIssue of Equity
14th Jan 20132:43 pmRNSIssue of Equity
8th Jan 20133:24 pmRNSDirector/PDMR Shareholding
17th Dec 20122:11 pmRNSIssue of Equity
10th Dec 20123:28 pmRNSDirector/PDMR Shareholding and issue of equity
4th Dec 20123:06 pmRNSIssue of Equity
21st Nov 20127:00 amRNSTrading Statement
8th Nov 20125:22 pmRNSDirector/PDMR Shareholding
5th Nov 20122:24 pmRNSDirector/PDMR Shareholding
5th Nov 201210:14 amRNSDirector's Details
29th Oct 20122:22 pmRNSDirector/PDMR Shareholding
9th Oct 201212:05 pmRNSDirector/PDMR Shareholding
3rd Oct 20122:28 pmRNSHolding(s) in Company
25th Sep 20126:28 pmRNSHolding(s) in Company
25th Sep 20127:00 amRNSHalf Yearly Report
7th Sep 20123:19 pmRNSDirector/PDMR Shareholding
6th Sep 201211:31 amRNSNotice of Results
31st Aug 20129:52 amRNSHolding(s) in Company
24th Aug 20127:00 amRNSDirector/PDMR Shareholding
22nd Aug 20123:44 pmRNSHolding(s) in Company
21st Aug 20127:00 amRNSDirector/PDMR Shareholding
8th Aug 20123:13 pmRNSDirector/PDMR Shareholding
23rd Jul 20125:34 pmRNSDirector/PDMR Shareholding
18th Jul 20127:00 amRNSTrading Statement
9th Jul 20125:43 pmRNSDirector/PDMR Shareholding
29th Jun 201212:17 pmRNSDirector/PDMR Shareholding
29th Jun 20127:00 amRNSDirector/PDMR Shareholding
22nd Jun 20127:00 amRNSDirector/PDMR Shareholding
21st Jun 20125:17 pmRNSHolding(s) in Company
7th Jun 20124:36 pmRNSDirector/PDMR Shareholding
30th May 20125:16 pmRNSResult of AGM
22nd May 20126:18 pmRNSDirector/PDMR Shareholding
17th May 20123:31 pmRNSHolding(s) in Company
17th May 20123:16 pmRNSHolding(s) in Company
16th May 20125:14 pmRNSHolding(s) in Company
11th May 201212:07 pmRNSDirector/PDMR Shareholding
10th May 201210:00 amRNSIssue of Equity
9th May 201211:33 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.